TABLE 1.
Results of studies investigating Borrelia burgdorferi in patients with morphea (and variants)
| AUTHOR | COUNTRY | N (TOTAL) | N (POSITIVE) | SEROLOGY | HISTOLOGY | IMMUNOHISTOCHEM | FFM | PCR | CULTURE |
|---|---|---|---|---|---|---|---|---|---|
| Aberer et al9 | Austria | 21 | 7 (33.3%) | X | |||||
| Aberer et al10 | Austria | 4 | 1 (25%) | X | |||||
| Aberer et al11 | Austria | 9 | 3 (33.3%) | X | |||||
| Aberer et al12 | Austria | 11 | 1 (9.1%) | X | |||||
| Breier et al13 | Austria | 1 | 1 (100%) | X | |||||
| Weber et al14 | Germany | 2 | 1 (50%) | X | |||||
| Schempp et al15 | Germany | 9 | 9 (100%) | X | |||||
| Schempp et al16 | Germany | 1 | 1 (100%) | X | X | ||||
| Weidenthaler et al17 | Germany | 1 | 1 (100%) | X | |||||
| Sommer et al18 | Germany | 12 | 0 (0%) | X | |||||
| Eisendle et al19 | Germany/Austria | 30 | 1 (3.3%) | X | |||||
| 122 | 84 (68.9) | X | |||||||
| Prinz et al20 | Germany/Hungary | 90 | 20 (22.2%) | X | |||||
| Trevisan et al21 | Italy | 10 | 6 (60%) | X | |||||
| Hercogova22 | Czech Republic | 1 | 1 (100%) | X | |||||
| Goodlad et al23 | Scotland | 14 | 0 (0%) | X | |||||
| O'zkan et al24 | Turkey | 10 | 3 (30%) | X | |||||
| Fujiwara et al25 | Japan | 5 | 2 (40%) | X | |||||
| Santos et al26 | Brazil | 15 | 3 (20%) | X | X | ||||
| Ross et al27 | United States | 25 | 10 (40%) | X | |||||
| Granter et al28 | United States | 1 | 1 (100%) | X | |||||
| Fan et al29 | United States | 31 | 0 (0%) | X |
FFM=focus floating microscopy; PCR=polymerase chain reaction; N=number (of patients/samples)